Published in J Urol on September 25, 2013
Initiative to Minimize Disparities in Postoperative Prostate Cancer Care | NCT03755492
Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology (2015) 1.48
Nightly sildenafil use after radical prostatectomy has adverse effects on urinary convalescence: Results from a randomized trial of nightly vs on-demand dosing regimens. Can Urol Assoc J (2015) 1.40
Nomograms in oncology: more than meets the eye. Lancet Oncol (2015) 1.21
Sexual dysfunction and infertility as late effects of cancer treatment. EJC Suppl (2014) 0.87
Erection rehabilitation following prostatectomy - current strategies and future directions. Nat Rev Urol (2016) 0.81
Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int (2015) 0.80
Are we ready to predict late effects? A systematic review of clinically useful prediction models. Eur J Cancer (2015) 0.78
Editorial comment. J Urol (2013) 0.75
Racial and Ethnic Variation in Health-Related Quality of Life Scores Prior to Prostate Cancer Treatment. Sex Med (2017) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol (1992) 13.63
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology (2000) 6.42
The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care (1998) 4.34
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Identifying meaningful intra-individual change standards for health-related quality of life measures. J Eval Clin Pract (2000) 2.47
Prediction of functional outcomes after nerve-sparing radical prostatectomy: results of conditional survival analyses. Eur Urol (2012) 1.93
Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite. Cancer (2008) 1.71
Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol (1999) 1.58
Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol (2013) 1.07
Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy. J Urol (2009) 1.00
Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments. Prostate Cancer Prostatic Dis (2013) 0.98
Clinical interpretation of the Expanded Prostate Cancer Index Composite-Short Form sexual summary score. J Urol (2009) 0.96
The association of Incontinence Symptom Index scores with urethral function and support. Am J Obstet Gynecol (2008) 0.88
Stratification of postprostatectomy urinary function using expanded prostate cancer index composite. Urology (2012) 0.84
To predict the future, consider the present as well as the past. Eur Urol (2012) 0.82
The prostate health index selectively identifies clinically significant prostate cancer. J Urol (2014) 2.68
Satisfaction with information used to choose prostate cancer treatment. J Urol (2013) 2.06
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. J Urol (2016) 0.77